169 related articles for article (PubMed ID: 25104288)
21. Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.
Hyare H; Rice L; Thust S; Nachev P; Jha A; Milic M; Brandner S; Rees J
Eur J Radiol; 2019 May; 114():120-127. PubMed ID: 31005161
[TBL] [Abstract][Full Text] [Related]
22. Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?
Fellah S; Caudal D; De Paula AM; Dory-Lautrec P; Figarella-Branger D; Chinot O; Metellus P; Cozzone PJ; Confort-Gouny S; Ghattas B; Callot V; Girard N
AJNR Am J Neuroradiol; 2013 Jul; 34(7):1326-33. PubMed ID: 23221948
[TBL] [Abstract][Full Text] [Related]
23. Arterial spin-labeling assessment of normalized vascular intratumoral signal intensity as a predictor of histologic grade of astrocytic neoplasms.
Furtner J; Schöpf V; Schewzow K; Kasprian G; Weber M; Woitek R; Asenbaum U; Preusser M; Marosi C; Hainfellner JA; Widhalm G; Wolfsberger S; Prayer D
AJNR Am J Neuroradiol; 2014 Mar; 35(3):482-9. PubMed ID: 23945226
[TBL] [Abstract][Full Text] [Related]
24. Observer reliability in histological grading of astrocytoma stereotactic biopsies.
Mittler MA; Walters BC; Stopa EG
J Neurosurg; 1996 Dec; 85(6):1091-4. PubMed ID: 8929500
[TBL] [Abstract][Full Text] [Related]
25. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
Thotakura M; Tirumalasetti N; Krishna R
J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
[TBL] [Abstract][Full Text] [Related]
26. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
27. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
[TBL] [Abstract][Full Text] [Related]
28. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
[TBL] [Abstract][Full Text] [Related]
29. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
[TBL] [Abstract][Full Text] [Related]
30. Apparent diffusion coefficient in the evaluation of cerebral gliomas malignancy.
Ignjatović J; Stojanov D; Zivković V; Ljubisavljević S; Stojanović N; Stefanović I; Benedeto-Stojanović D; Ignjatović N; Petrović S; Aracki-Trenkić A; Radovanović Z; Lazović L
Vojnosanit Pregl; 2015 Oct; 72(10):870-5. PubMed ID: 26665552
[TBL] [Abstract][Full Text] [Related]
31. Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.
Sallinen PK; Sallinen SL; Helén PT; Rantala IS; Rautiainen E; Helin HJ; Kalimo H; Haapasalo HK
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):319-31. PubMed ID: 10931365
[TBL] [Abstract][Full Text] [Related]
32. A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.
Steidl E; Filipski K; Zeiner PS; Wagner M; Fokas E; Forster MT; Ronellenfitsch MW; Divé I; Steinbach JP; Harter PN; Bähr O
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2373-2383. PubMed ID: 33538917
[TBL] [Abstract][Full Text] [Related]
33. Discrimination between Glioma Grades II and III Using Dynamic Susceptibility Perfusion MRI: A Meta-Analysis.
Delgado AF; Delgado AF
AJNR Am J Neuroradiol; 2017 Jul; 38(7):1348-1355. PubMed ID: 28522666
[TBL] [Abstract][Full Text] [Related]
34. Grading of astrocytomas. A simple and reproducible method.
Daumas-Duport C; Scheithauer B; O'Fallon J; Kelly P
Cancer; 1988 Nov; 62(10):2152-65. PubMed ID: 3179928
[TBL] [Abstract][Full Text] [Related]
35. Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.
Vettukattil R; Gulati M; Sjøbakk TE; Jakola AS; Kvernmo NA; Torp SH; Bathen TF; Gulati S; Gribbestad IS
Neurosurgery; 2013 Feb; 72(2):186-95; discussion 195. PubMed ID: 23147779
[TBL] [Abstract][Full Text] [Related]
36. Aquaporin Positron Emission Tomography Differentiates Between Grade III and IV Human Astrocytoma.
Suzuki Y; Nakamura Y; Yamada K; Kurabe S; Okamoto K; Aoki H; Kitaura H; Kakita A; Fujii Y; Huber VJ; Igarashi H; Kwee IL; Nakada T
Neurosurgery; 2018 Jun; 82(6):842-846. PubMed ID: 28645205
[TBL] [Abstract][Full Text] [Related]
37. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
Shirahata M; Ono T; Stichel D; Schrimpf D; Reuss DE; Sahm F; Koelsche C; Wefers A; Reinhardt A; Huang K; Sievers P; Shimizu H; Nanjo H; Kobayashi Y; Miyake Y; Suzuki T; Adachi JI; Mishima K; Sasaki A; Nishikawa R; Bewerunge-Hudler M; Ryzhova M; Absalyamova O; Golanov A; Sinn P; Platten M; Jungk C; Winkler F; Wick A; Hänggi D; Unterberg A; Pfister SM; Jones DTW; van den Bent M; Hegi M; French P; Baumert BG; Stupp R; Gorlia T; Weller M; Capper D; Korshunov A; Herold-Mende C; Wick W; Louis DN; von Deimling A
Acta Neuropathol; 2018 Jul; 136(1):153-166. PubMed ID: 29687258
[TBL] [Abstract][Full Text] [Related]
38. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
39. Imaging-Based Algorithm for the Local Grading of Glioma.
Gates EDH; Lin JS; Weinberg JS; Prabhu SS; Hamilton J; Hazle JD; Fuller GN; Baladandayuthapani V; Fuentes DT; Schellingerhout D
AJNR Am J Neuroradiol; 2020 Mar; 41(3):400-407. PubMed ID: 32029466
[TBL] [Abstract][Full Text] [Related]
40. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
